Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Immunology

• Publication date

  2006-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CLIM.2006.03.005PMID 16631408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase‐3β

  2006cited by this paper
• Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.

  2005cited by this paper
• Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3

  2005cited by this paper
• GSK-3β inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat*

  2005cited by this paper
• Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity.

  2004cited by this paper
• Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to

  2004cited by this paper
• Nuclear factor (NF)-κB proteins: therapeutic targets*

  2004cited by this paper
• Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.

  2004cited by this paper
• Nuclear factor (NF)-kappaB proteins: therapeutic targets.

  2004cited by this paper
• Genetic Deletion of Glycogen Synthase Kinase-3β Abrogates Activation of IκBα Kinase, JNK, Akt, and p44/p42 MAPK but Potentiates Apoptosis Induced by Tumor Necrosis Factor*

  2004cited by this paper
• Phosphorylation of Serine 468 by GSK-3β Negatively Regulates Basal p65 NF-κB Activity*

  2004cited by this paper
• Cyclooxygenase‐2 (COX‐2) in Inflammatory and Degenerative Brain Diseases

  2004cited by this paper
• Hypertonic Stress Activates Glycogen Synthase Kinase 3β-mediated Apoptosis of Renal Medullary Interstitial Cells, Suppressing an NFκB-driven Cyclooxygenase-2-dependent Survival Pathway*

  2003cited by this paper
• Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes.

  2002cited by this paper
• Phosphoinositol 3 kinase inhibitor, LY294002 increases bcl-2 protein and inhibits okadaic acid-induced apoptosis in Bcl-2 expressing renal epithelial cells

  2002cited by this paper
• Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes

  2002cited by this paper
• First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.

  2002cited by this paper
• Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis

  2001cited by this paper
• Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic.

  2001cited by this paper
• Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury.

  2001cited by this paper
• Judging a Protein by More Than Its Name: GSK-3

  2001cited by this paper
• Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis.

  2000cited by this paper
• Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

  2000cited by this paper
• Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

  2000cited by this paper
• Cytokines in rheumatoid arthritis: trials and tribulations.

  2000cited by this paper
• Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.

  1999cited by this paper
• Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene

  1999cited by this paper
• Role of IL-6 in the pleurisy and lung injury caused by carrageenan.

  1999cited by this paper
• Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation.

  1998cited by this paper
• Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase.

  1998cited by this paper
• Effect of calpain inhibitor I, an inhibitor of the proteolysis of IκB, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat

  1997cited by this paper
• Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

  1995cited by this paper
• Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB

  1995cited by this paper
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

  1995cited by this paper
• A perspective on anti-cytokine and anti-T cell-directed therapies in rheumatoid arthritis.

  1995cited by this paper
• A perspective on anti-cytokine and anti-T cell-directed therapies in rheumatoid arthritis.

  1995cited by this paper
• Regulation of neutrophil-derived chemokine expression by IL-10.

  1994cited by this paper
• T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ

  1993cited by this paper
• Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta

  1993cited by this paper
• T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta.

  1993cited by this paper
• Molecular and biochemical features of poly (ADP-ribose) metabolism

  1993cited by this paper
• Rheumatoid arthritis. Pathophysiology and implications for therapy.

  1990cited by this paper
• Type II Collagen Autoimmunity in Animals and Provocations Leading to Arthritis

  1990cited by this paper
• Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

  1990cited by this paper
• The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.

  1989cited by this paper
• Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits.

  1985cited by this paper
• Collagen autoimmune arthritis.

  1984cited by this paper
• Glycogen synthase kinase-3 from rabbit skeletal muscle.

  1981cited by this paper
• Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase.

  1980cited by this paper

• Genistein promotes cartilage repair and inhibits synovial inflammatory response after anterior cruciate ligament transection in rats by regulating the Wnt/β-catenin axis

  2024cites this paper
• Macrophage re-programming by JAK inhibitors relies on MAFB

  2024cites this paper
• Cytocompatibility and Osteoinductive Properties of Collagen-Fibronectin Hydrogel Impregnated with siRNA Targeting Glycogen Synthase Kinase 3β: In Vitro Study

  2023cites this paper
• Impact of glycogen synthase kinase-3ß inhibition on rats' temporomandibular joint collagen-induced rheumatoid arthritis with correlation to miRNA-155/miRNA-24 expression.

  2023cites this paper
• Suppression of Nitrosative Stress and Inflammation of the Knee Joint Synovium in Collagen Type II-Induced Rheumatoid Arthritis by the Inhibition of Glycogen Synthase Kinase-3ß

  2022influential citation
• Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis

  2022cites this paper
• Aloe polymeric acemannan inhibits the cytokine storm in mouse pneumonia models by modulating macrophage metabolism.

  2022cites this paper
• Micro RNAs 26b, 20a inversely correlate with GSK-3 β/NF-κB/NLRP-3 pathway to highlight the additive promising effects of atorvastatin and quercetin in experimental induced arthritis.

  2021cites this paper
• Underlying mechanisms of glucocorticoid-induced β-cell death and dysfunction: a new role for glycogen synthase kinase 3

  2021cites this paper
• TDZD-8 Suppresses Rheumatoid Arthritis Induced by Collagen Type II in Rats: Potential Role of Apoptosis and Inflammation

  2021cites this paper
• Glycogen synthase kinase 3 alpha/beta deletion induces precocious growth plate remodeling in mice

  2021cites this paper
• Inhibition of GSK3β protects against collagen type II‐induced arthritis associated with a decrease in synovial leukocyte infiltration and inhibition of endoplasmic reticulum stress and autophagy biomarkers

  2020cites this paper
• GSK3: A Kinase Balancing Promotion and Resolution of Inflammation

  2020influential citation
• Glycogen synthase kinase 3 alpha/beta deletion induces precocious growth plate remodeling and cell loss in mice

  2020cites this paper
• The role of glycogen synthase kinase 3 beta in multiple sclerosis.

  2020cites this paper
• Cataloguing the phosphorylation sites of tristetraprolin (TTP): Functional implications for inflammatory diseases.

  2020cites this paper
• Granulocytic Myeloid-Derived Suppressor Cell Exosomal Prostaglandin E2 Ameliorates Collagen-Induced Arthritis by Enhancing IL-10+ B Cells

  2020cites this paper
• Screening of a Panel of Low Molecular Weight Compounds That Inhibit Synovial Fibroblast Invasion in Rheumatoid Arthritis

  2020cites this paper
• Protective Mechanism of MIF Inhibitor ISO-1 on Intrahepatic Bile Duct Cells in Rats with Severe Acute Pancreatitis

  2020cites this paper
• Implication of glycogen synthase kinase 3 in diabetes-associated islet inflammation.

  2020cites this paper
• Protective effect of a new hyaluronic acid -carnosine conjugate on the modulation of the inflammatory response in mice subjected to collagen-induced arthritis.

  2020cites this paper
• Inhibition of glycogen synthase kinase-3β protects against collagen type II-induced arthritis associated with the inhibition of miR155/24 and inflammation and upregulation of apoptosis in rats

  2020influential citation
• Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report

  2020cites this paper
• GSK-3 Inhibitors and Tooth Repair: An Ethical Analysis

  2019cites this paper
• Risk of Wnt/β-catenin signalling pathway gene polymorphisms in primary Sjögren's syndrome.

  2019cites this paper
• Inhibiting Effect of Lithium Chloride on Endotoxin-induced Uveitis in Rats

  2018cites this paper
• The Effects of the Gsk-3 Inhıbıtor Tdzd-8 on Bıpolar-Lıke Behavıoral Phenotype Induced by Hıgh Fructose Corn Syrup Consumptıon in Adolescent Rats

  2018cites this paper
• Knowledge-Based Neuroendocrine Immunomodulation (NIM) Molecular Network Construction and Its Application

  2018cites this paper
• Oxazolo[4,5‐b]pyridine‐Based Piperazinamides as GSK‐3β Inhibitors with Potential for Attenuating Inflammation and Suppression of Pro‐Inflammatory Mediators

  2017cites this paper
• Myeloid ‐ derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders ( Review )

  2017cites this paper
• Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders.

  2017cites this paper
• Glycogen Synthase Kinase-3β Inhibition Links Mitochondrial Dysfunction, Extracellular Matrix Remodelling and Terminal Differentiation in Chondrocytes

  2017cites this paper
• Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host disease

  2017cites this paper
• Camellia Sinensis Modulates Telomerase in Collagen-Induced Arthritis

  2017cites this paper
• Synthesis of Novel Oxazolo[4,5‐b]pyridine‐2‐one based 1,2,3‐triazoles as Glycogen Synthase Kinase‐3β Inhibitors with Anti‐inflammatory Potential

  2016cites this paper
• Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation.

  2016cites this paper
• Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.

  2016cites this paper
• Effects of Paeonol on Anti-Neuroinflammatory Responses in Microglial Cells

  2015cites this paper
• Neuroprotective strategies for transient focal cerebral ischemia : an experimental model

  2015cites this paper
• Anti-Inflammatory Effects and Joint Protection in Collagen-Induced Arthritis after Treatment with IQ-1S, a Selective c-Jun N-Terminal Kinase Inhibitor

  2015cites this paper
• Administration of NaHS Attenuates Footshock-Induced Pathologies and Emotional and Cognitive Dysfunction in Triple Transgenic Alzheimer’s Mice

  2015cites this paper
• Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

  2015cites this paper
• Selecting dietary-derived bioactives which protect cartilage from destruction in osteoarthritis

  2015cites this paper
• Pulmonary , gastrointestinal and urogenital pharmacology Inhibition of glycogen synthase kinase ( GSK )-3-β improves liver microcirculation and hepatocellular function after hemorrhagic shock $

  2014cites this paper
• Kinetics of glycogen synthase kinase (GSK)3β and phosphorylated GSK3β (Ser 9) expression in experimentally induced periapical lesions.

  2014cites this paper
• Glycogen Synthase Kinase 3 Inhibition Stimulates Human Cartilage Destruction and Exacerbates Murine Osteoarthritis

  2014influential citation
• Targets and Small Molecules Against Tauopathies. Part 1: From Genes to Soluble, Aggregation-Prone Tau Proteins

  2014cites this paper
• Inhibition of glycogen synthase kinase-3β attenuates acute kidney injury in sodium taurocholate‑induced severe acute pancreatitis in rats.

  2014cites this paper
• Inhibition of glycogen synthase kinase-3β suppresses inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes and collagen-induced arthritis.

  2014cites this paper
• TDZD-8 pre-treatment in transient middle cerebral artery occlusion

  2014cites this paper
• Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits

  2014cites this paper
• GSK3 inhibition prevents lethal GVHD in mice.

  2013cites this paper
• Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice

  2013cites this paper
• Modulation of temporomandibular joint nociception and inflammation in male rats after administering a physiological concentration of 17β‐oestradiol

  2013cites this paper
• Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer's disease.

  2013cites this paper
• New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

  2012cites this paper
• Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells

  2012cites this paper
• Glycogen synthase kinase-3β regulates anti-inflammatory property of fluoxetine.

  2012cites this paper
• Identificación y análisis de nuevas dianas celulares con efecto neurogénico y neuroprotector

  2011cites this paper
• Mechanisms of lithium ’ s neuroprotective actions 2 . 1 Lithium as a multi-functional neuroprotectant

  2011cites this paper
• Glycogen Synthase Kinase-3 Facilitates Con A-Induced IFN-γ–Mediated Immune Hepatic Injury

  2011cites this paper
• Glycogen synthase kinase 3: a point of convergence for the host inflammatory response.

  2011cites this paper
• This information is current as Injury Mediated Immune Hepatic − γ A-Induced IFN-Glycogen Synthase Kinase-3 Facilitates

  2011cites this paper
• The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice.

  2011cites this paper
• Glycogen synthase kinase-3 regulates cigarette smoke extract- and IL-1β-induced cytokine secretion by airway smooth muscle.

  2011cites this paper
• META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.

  2010cites this paper
• Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8

  2010cites this paper
• Lithium protects cartilage from cytokine-mediated degradation by reducing collagen-degrading MMP production via inhibition of the P38 mitogen-activated protein kinase pathway.

  2010cites this paper
• Glycogen synthase kinase‐3β indirectly facilitates interferon‐γ‐induced nuclear factor‐κB activation and nitric oxide biosynthesis

  2010cites this paper
• Using small molecule GSK3β inhibitors to treat inflammation.

  2010cites this paper
• Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).

  2010cites this paper
• Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells.

  2010cites this paper
• Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

  2010cites this paper
• Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.

  2009cites this paper
• Glycogen Synthase Kinase-3β Facilitates IFN-γ-Induced STAT1 Activation by Regulating Src Homology-2 Domain-Containing Phosphatase 21

  2009cites this paper
• Glycogen synthase kinase‐3 negatively regulates anti‐inflammatory interleukin‐10 for lipopolysaccharide‐induced iNOS/NO biosynthesis and RANTES production in microglial cells

  2009cites this paper
• Cartilage Tissue Engineering; the search for chondrogenic progenitor cells and associated signalling pathways

  2009cites this paper
• Phosphatase 2 Src Homology-2 Domain-Containing-Induced STAT 1 Activation by Regulating γ Facilitates IFN-β Glycogen Synthase Kinase-3

  2009cites this paper
• Staphylococcus aureus Induces Microglial Inflammation via a Glycogen Synthase Kinase 3β-Regulated Pathway

  2009cites this paper
• Rho iso-alpha acids from hops inhibit the GSK-3/NF-κB pathway and reduce inflammatory markers associated with bone and cartilage degradation

  2009cites this paper
• META060 inhibits multiple kinases in the NF-κB pathway and suppresses LPS – mediated inflammation in vitro and ex vivo

  2009cites this paper
• Rho-Iso-Alpha Acids and Tetrahydro-Iso-Alpha Acids Are Selective Protein Kinase Inhibitors which Potently Reduce Inflammation in Macrophages In Vitro and in the Collagen-Induced Rheumatoid Arthritis Model In Vivo

  2009cites this paper
• GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics.

  2009cites this paper
• Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity.

  2009cites this paper
• Inhibiting glycogen synthase kinase‐3 reduces endotoxaemic acute renal failure by down‐regulating inflammation and renal cell apoptosis

  2009influential citation
• Lithium Prevents and Ameliorates Experimental Autoimmune Encephalomyelitis1

  2008cites this paper
• Looking at lithium: molecular moods and complex behaviour.

  2008cites this paper
• Preclinical efficacy on GSK‐3 inhibitors: Towards a future generation of powerful drugs

  2008cites this paper
• IFN‐γ synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase‐3‐inhibited IL‐10

  2008cites this paper
• Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.

  2008cites this paper
• Lithium Prevents and Ameliorates

  2008cites this paper
• The role of glycogen synthase kinase-3beta in normal haematopoiesis, angiogenesis and leukaemia.

  2008cites this paper
• Glycogen synthase kinase-3beta inhibition attenuates asthma in mice.

  2007cites this paper
• Glycogen Synthase Kinase-3β Inhibition Attenuates the Development of Bleomycin-Induced Lung Injury

  2007cites this paper
• Glycogen synthase kinase-3β inhibition attenuates the development of ischaemia/reperfusion injury of the gut

  2007cites this paper
• Glycogen Synthase Kinase-3β Inhibition Attenuates Asthma in Mice

  2007cites this paper
• Effects of glycogen synthase kinase-3β inhibition on the development of cerulein-induced acute pancreatitis in mice

  2007cites this paper
• Effects of glycogen synthase kinase‐3[beta] inhibition on the development of cerulein‐induced acute pancreatitis in mice *

  2007cites this paper
• Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8).

  2007cites this paper
• Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics

  2007cites this paper